VOLUNTARY ANNOUNCEMENT-THE SUBMISSION OF NDA FOR SELINEXOR IN TAIWAN FOR THE TREATMENT OF THREE INDICATIONS IN HEMATOLOGIC MALIGNANCIES

Jul 14, 2021View PDF